Healthy adults
Conditions
Interventions
Intake two tablets of test food which contain test component (high dose) for twelve weeks
Intake two tablets of test food which contain test component (low dose) for twelve weeks
Intake two tablets of
Sponsors
Kagawa Nutrition University
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Healthy adults without serious illness. (2) Male. (3) 30 males aged 40-65 years. Subjects who voluntarily wish to participate in clinical trials and agreement with participating this study by written informed consent. (4) Subjects who can maintain regular daily habits during the test period. (5) In principle, subjects who are taking medication for treatment of chronic diseases (high blood pressure, etc.) or are going to the hospital are excluded. If the condition is mild, their participation will be considered by the principal investigator.
Exclusion criteria
Exclusion criteria: (1) Subjects who are currently receiving medication or going to the hospital. (2) Subjects who have previous medical history of serious disease or chronic disease. (3) Subjects who have allergy to foods or medicines. (4) Subjects who were participating other clinical test within the past 1 month. (5) Subjects who constantly use Food for Specified Health Uses(FOSHU) or functional foods, etc. (6) Subjects who eat and drink excessively or have extremely irregular dietary habits. (7) Subjects judged as unsuitable for the study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood microRNA level | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood biochemical test Safety evaluation | — |
Countries
Japan
Contacts
Public ContactRyosuke Matsuoka
Kewpie Corporation R&D Division
Outcome results
None listed